Fellows
Michael J. Slade

Michael J. Slade, MD

First-year Fellow

Began fellowship in 2020

Co-Chief Fellow (July 2021-June 2023)

Biosketch

Education
2006-2011 BA, University of Georgia, Athens, GA
2012-2017 MD, Washington University, St. Louis, MO
Post-graduate Training
2017-2020 Residency, Internal Medicine, Barnes-Jewish Hospital/Washington University, St. Louis, MO
Honors & Awards
2017 Inpatient Intern of the Month (July)
2018 Inpatient Resident of the Month (October)
2019 R25 STRENGTH Program Scholar in Cancer Genomics
2019 Mentors in Medicine Research Award
2019 American Society of Hematology HONORS Award

Peer Reviewed Journal Articles

  • CD123 Bi-Specific Antibodies in Development in AML: What Do We Know So Far?
    Slade MJ, Uy GL
    Best Pract Res Clin Haematol 2020 Dec;33(4):101219
  • The Effect of Donor Type on Outcomes in Adults With Acute Myeloid Leukemia After Reduced-Intensity Hematopoietic Peripheral Blood Cell Transplant - A Retrospective Study
    Rashid N, Slade M, Abboud R, Gao F, DiPersio JF, Westervelt P, Uy G, Stockerl-Goldstein K, Romee R, Schroeder MA
    Transpl Int 2020 Sep;33(9):1089-1098
  • Can Planned CD34+ Stem Cell Boost Prevent Poor Graft Function After Peripheral Blood Haploidentical Hematopoietic Transplantation?
    Abboud R, Slade M, Abboud C, DiPersio JF
    Leuk Lymphoma 2020 Nov 2:1-3; [Epub ahead of print]
  • The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-Versus-Host Disparity Is Associated With Increased Acute Graft-Versus-Host Disease in Haploidentical Transplantation With Post-Transplantation Cyclophosphamide
    Rimando J, Slade M, DiPersio JF, Westervelt P, Gao F, Liu C, Romee R
    Biol Blood Marrow Transplant 2020 Jan;26(1):123-131
  • Cutaneous Graft-Versus-Host Disease Incidence Is Similar in Haploidentical and Matched Unrelated Hematopoietic Transplant Recipients: A Retrospective Cohort Study
    Heberton MM, Tripathi S, Slade M, Trinkaus K, Romee R, Anadkat M
    J Am Acad Dermatol 2019 Nov 2; [Epub ahead of print]
  • HLA Epitope Mismatch in Haploidentical Transplantation Is Associated With Decreased Relapse and Delayed Engraftment
    Rimando J, Slade M, DiPersio JF, Westervelt P, Gao F, Liu C, Romee R
    Blood Adv 2018 Dec 26;2(24):3590-3601
  • Propensity Score Analysis of Conditioning Intensity in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation
    Huselton E, Slade M, Trinkaus KM, DiPersio JF, Westervelt P, Romee R
    Biol Blood Marrow Transplant 2018 Oct;24(10):2047-2055
  • Donor-Derived Smoldering Multiple Myeloma Following a Hematopoietic Cell Transplantation for AML
    Fakhri B, Fiala M, Slade M, Westervelt P, Ghobadi A
    Case Rep Hematol 2017;2017:3728429
  • Donor-Lymphocyte Infusion Following Haploidentical Hematopoietic Cell Transplantation With Peripheral Blood Stem Cell Grafts and PTCy
    Goldsmith SR, Slade M, DiPersio JF, Westervelt P, Schroeder MA, Gao F, Romee R
    Bone Marrow Transplant 2017 Dec;52(12):1623-1628
  • Haploidentical Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults With Acute Myeloid Leukemia or Myelodysplastic Syndrome
    Slade M, DiPersio JF, Westervelt P, Vij R, Schroeder MA, Romee R
    Biol Blood Marrow Transplant 2017 Oct;23(10):1736-1743
  • Untreated Donor Specific Antibodies Against HLA Are Associated With Poor Outcomes in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation
    Zou J, Romee R, Slade M, Phelan D, Keller J, Mohanakumar T, Grossman BJ
    Bone Marrow Transplant 2017 Jun;52(6):898-901
  • Cardiomyopathy in Patients After Posttransplant Cyclophosphamide-Based Hematopoietic Cell Transplantation
    Lin CJ, Vader JM, Slade M, DiPersio JF, Westervelt P, Romee R
    Cancer 2017 May 15;123(10):1800-1809
  • Single Institution Experience With G-CSF Mobilized T-Cell Replete Haploidentical Hematopoietic Cell Transplantation
    Huselton E, Slade M, DiPersio JF, Westervelt P, Vij R, Uy GL, Fehniger TA, Abboud CN, Gao F, Schroeder MA, Romee R
    Bone Marrow Transplant 2017 May;52(5):769-771
  • Rapid Detection of Donor Cell Free DNA in Lung Transplant Recipients With Rejections Using Donor-Recipient HLA Mismatch
    Zou J, Duffy B, Slade M, Young AL, Steward N, Hachem R, Mohanakumar T
    Hum Immunol 2017 Apr;78(4):342-349
  • T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation From Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia
    How J, Slade M, Vu K, DiPersio JF, Westervelt P, Uy GL, Abboud CN, Vij R, Schroeder MA, Fehniger TA, Romee R
    Biol Blood Marrow Transplant 2017 Apr;23(4):648-653
  • Epidemiology of Infections Following Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
    Slade M, Goldsmith S, Romee R, DiPersio JF, Dubberke ER, Westervelt P, Uy GL, Lawrence SJ
    Transpl Infect Dis 2017 Feb;19(1)
  • Haploidentical Transplantation With Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia
    Srour SA, Milton DR, Bashey A, Karduss-Urueta A, Al Malki MM, Romee R, Solomon S, Nademanee A, Brown S, Slade M, Perez R, Rondon G, Forman SJ, Champlin RE, Kebriaei P, Ciurea SO
    Biol Blood Marrow Transplant 2017 Feb;23(2):318-324
  • The Impact of Diabetes Mellitus and Other Comorbidities on Hematopoietic Stem Cell Collection and Hematologic Recovery Post-Transplantation
    Fiala MA, Slade M, Wang S, Park S, DiPersio J, Stockerl-Goldstein K
    Leuk Lymphoma 2017 Jan;58(1):241-243
  • Halfway There: The Past, Present and Future of Haploidentical Transplantation
    Slade M, Fakhri B, Savani BN, Romee R
    Bone Marrow Transplant 2017 Jan;52(1):1-6
  • Post-Transplant High-Dose Cyclophosphamide After HLA-Matched Vs Haploidentical Hematopoietic Cell Transplantation for AML
    Rashidi A, Slade M, DiPersio JF, Westervelt P, Vij R, Romee R
    Bone Marrow Transplant 2016 Dec;51(12):1561-1564
  • Cytomegalovirus Viremia, Disease, and Impact on Relapse in T-Cell Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide
    Goldsmith SR, Slade M, DiPersio JF, Westervelt P, Lawrence SJ, Uy GL, Abboud CN, Vij R, Schroeder MA, Fehniger TA, Dubberke ER, Trinkaus K, Romee R
    Haematologica 2016 Nov;101(11):e465-e468
  • Severe Cytokine-Release Syndrome After T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated With Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated
    Abboud R, Keller J, Slade M, DiPersio JF, Westervelt P, Rettig MP, Meier S, Fehniger TA, Abboud CN, Uy GL, Vij R, Trinkaus KM, Schroeder MA, Romee R
    Biol Blood Marrow Transplant 2016 Oct;22(10):1851-1860
  • Remobilization of Hematopoietic Stem Cells in Healthy Donors for Allogeneic Transplantation
    Fiala MA, Park S, Slade M, DiPersio JF, Stockerl-Goldstein KE
    Transfusion 2016 Sep;56(9):2331-5